Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Lexicon Pharmaceuticals, Inc., The Woodlands (United States of America)
6 More presentations in this session
Associate Professor W. Wongcharoen (Chiang Mai, TH)
Doctor A. Ferreira (Lisbon, PT)
Doctor R. Rascon Sabido (Veracruz, MX)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
